Biologics are highly complex and often expensive therapies.
A biosimilar is a biologic deemed highly similar to an already approved
biologic medicine, known as a reference product. This similarity is confirmed
through a number of tests, both in the lab and in clinical research.1
A biosimilar manufacturer must demonstrate that its proposed biosimilar
product has no clinically meaningful differences from the reference product
in terms of safety, purity, and effectiveness.
VIATRIS and the Viatris Logo are trademarks of Mylan Inc., a Viatris Company.
GLOBAL HEALTHCARE GATEWAY is a registered trademark of Mylan Inc., a Viatris Company.
MYLAN, INC. AND BIOSIMILARS WITHOUT BORDERS ARE NOT IN ANY WAY AFFILIATED WITH DOCTORS WITHOUT BORDERS OR MÉDECINS SANS FRONTIÈRES. DOCTORS WITHOUT BORDERS AND MÉDECINS SANS FRONTIÈRES ARE REGISTERED TRADEMARKS OF MÉDECINS SANS FRONTIÈRES INTERNATIONAL.